Raffi, F., Rachlis, A., Brinson, C., Arasteh, K., Górgolas, M., Brennan, C., . . . Walmsley, S. (2015). Dolutegravir efficacy at 48 weeks in key subgroups of treatment-naive HIV-infected individuals in three randomized trials. AIDS.
Chicago Stili AlıntıRaffi, François, et al. "Dolutegravir Efficacy At 48 Weeks in Key Subgroups of Treatment-naive HIV-infected Individuals in Three Randomized Trials." AIDS 2015.
MLA AlıntıRaffi, François, et al. "Dolutegravir Efficacy At 48 Weeks in Key Subgroups of Treatment-naive HIV-infected Individuals in Three Randomized Trials." AIDS 2015.
Uyarı: Bu alıntı herzaman %100 doğru olmayabilir..